H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.9% of adults in Chesapeake have diagnosed diabetes — 0.9 points above the U.S. 12% figure. Census population 249,422. Virginia Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Chesapeake clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Chesapeake storefront.
PRP Joint Therapy Solutions in Chesapeake, VA for clinics & physicians. PRP joint therapy for knees, shoul… Compliance support & pricing — contact Hawk Medical.
Chesapeake is a city under 250k (249,422 Census). CDC PLACES (2023, crude) estimates 12.9% of adults in Chesapeake have diagnosed diabetes — 0.9 points above the U.S. 12% figure. Adult arthritis here is 26.5% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National PRP Joint Therapy Solutions notes (how the product actually works)JM reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Chesapeake is 12.9% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JM articles mapped. 8.2% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 12.9% of adults — 0.9 points above the U.S. 12% figure. Obesity is 40.1%; arthritis is 26.5%. That is place-level BRFSS modeling, not a clinic census and not a Chesapeake trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Virginia compliance risk.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Virginia.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Palmetto GBA LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
If you operate in Virginia and another MAC state, say it on the first call. JM will not port 1:1. We would rather split utilization than watch a sister clinic copy Chesapeake tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Chesapeake, VA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Chesapeake is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Chesapeake — 0.9 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Virginia Part B wound biologics follow this contractor (siblings: NC, SC, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Chesapeake. Useful for joint-program math; still needs a diagnosis and privileging.
No Chesapeake storefront. Joe Bradley is an active practice owner. prp joint therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.